Middle Mist Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and distributing a wide range of drugs and chemicals.
2015 | Kanchipuram, Tamil Nadu (India) | Active
Middle Mist Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.71 Cr
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.25 Cr
- Revenue Growth 13.10%
- Profit Growth 43.13%
- Ebitda 43.27%
- Net Worth 40.91%
- Total Assets 30.52%
About Middle Mist Pharmaceuticals
Middle Mist Pharmaceuticals Private Limited (MMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 August 2015 (Nine years and nine months 1 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.71 Cr.
The company currently has active open charges totaling ₹2.25 Cr.
Kuppusamy Ramadas and Rakesh Devarajan serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33100TN2015PTC101687
- Company No.
101687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Middle Mist Pharmaceuticals Private Limited
Explore comprehensive data for Middle Mist Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Middle Mist Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Devarajan  | Whole-Time Director | 05-Aug-2015 | Current |
Kuppusamy Ramadas  | Whole-Time Director | 05-Aug-2015 | Current |
Financial Performance of Middle Mist Pharmaceuticals.
Middle Mist Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.1% increase. The company also saw a substantial improvement in profitability, with a 43.13% increase in profit. The company's net worth Soared by an impressive increase of 40.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Middle Mist Pharmaceuticals?
In 2024, Middle Mist Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Verax Lifesciences Private Limited
Kuppusamy Ramadas is a mutual person
- Dr. Norman Laboratories Private Limited
Kuppusamy Ramadas is a mutual person
Charges (Loans)
Open Charges
₹2.25 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
- Axis Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2024 | Others | ₹2.00 Cr | Open |
| 02 May 2022 | Axis Bank Limited | ₹2.50 M | Open |
How Many Employees Work at Middle Mist Pharmaceuticals?
Unlock and access historical data on people associated with Middle Mist Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Middle Mist Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Middle Mist Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Middle Mist Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Middle Mist Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Middle Mist Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
- Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100882587 was registered on 17 Jan 2024.
- Charges
A charge with Axis Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100572081 was registered on 02 May 2022.
- Director Appointment
Kuppusamy Ramadas was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 05 Aug 2015 & has been associated with this company since 9 years 9 months .
- Director Appointment
Rakesh Sharma Devarajan was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 05 Aug 2015 & has been associated with this company since 9 years 9 months .
Frequently asked questions
What is the Incorporation or founding date of Middle Mist Pharmaceuticals Private Limited?
Middle Mist Pharmaceuticals Private Limited was incorporated on 05 Aug 2015.
What is authorized share capital and paid-up capital of Middle Mist Pharmaceuticals Private Limited?
The authorized share capital of Middle Mist Pharmaceuticals Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 4.71 Cr.
Who are the current board members & directors of Middle Mist Pharmaceuticals Private Limited?
Currently 2 directors are associated with Middle Mist Pharmaceuticals Private Limited.
- Kuppusamy Ramadas
- Rakesh Sharma Devarajan
What is the registered address of Middle Mist Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Middle Mist Pharmaceuticals Private Limited is Door No.1/230 Leelavathi Nagar Kundrathur Main Road, Chikarayapuram India, Chennai, Tamil Nadu, 600069.
What is the corporate identification number (CIN) and company number of Middle Mist Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Middle Mist Pharmaceuticals Private Limited is U33100TN2015PTC101687 and the company number is 101687 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Middle Mist Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Middle Mist Pharmaceuticals Private Limited has risen by 13.10%.
What change has been observed in the net worth of Middle Mist Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Middle Mist Pharmaceuticals Private Limited has experienced an upsurge of 40.91%.
What are the total open charges for Middle Mist Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Middle Mist Pharmaceuticals Private Limited amount to ₹ 2.25 Cr.
When was the last Balance Sheet of Middle Mist Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Middle Mist Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records